Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Annemarie M, Schilder"'
Autor:
Marjan Ghiti Moghadam, Femke B. G. Lamers-Karnebeek, Harald E. Vonkeman, Peter M. ten Klooster, Janneke Tekstra, Barbara van Schaeybroeck, Ruth Klaasen, Marieke van Onna, Hein J. Bernelot Moens, Henk Visser, Annemarie M. Schilder, Marc R. Kok, Robert B. M. Landewé, Piet L. C. M. van Riel, Mart A. F. J. van de Laar, Tim L. Jansen, on behalf of the Dutch National POET Collaboration
Publikováno v:
BMC Rheumatology, Vol 3, Iss 1, Pp 1-8 (2019)
Abstract Background The aim of this study was to identify predictors of prolonged disease control after discontinuation of tumor necrosis factor inhibitor (TNFi) treatment in patients with rheumatoid arthritis (RA). Methods Post-hoc analysis of 439 R
Externí odkaz:
https://doaj.org/article/ddbedcb42a224131ae7c3a0b9702e2e3
Autor:
Marjan Ghiti Moghadam, Femke B G Lamers-Karnebeek, Harald E Vonkeman, Peter M Ten Klooster, Janneke Tekstra, Annemarie M Schilder, Henk Visser, Eric H Sasso, David Chernoff, Willem F Lems, Dirk-Jan van Schaardenburg, Robert Landewe, Hein J Bernelot Moens, Timothy R D J Radstake, Piet L C M van Riel, Mart A F J van de Laar, Tim L Jansen, Dutch National POET Collaboration
Publikováno v:
PLoS ONE, Vol 13, Iss 5, p e0192425 (2018)
Successfully stopping or reducing treatment for patients with rheumatoid arthritis (RA) in low disease activity (LDA) may improve cost-effectiveness of care. We evaluated the multi-biomarker disease activity (MBDA) score as a predictor of disease rel
Externí odkaz:
https://doaj.org/article/931061a4243b42b79f19e460a8f6321b
Autor:
Harald E. Vonkeman, Ruth Klaasen, Barbara van Schaeybroeck, Marjan Ghiti Moghadam, Henk Visser, Hein J. Bernelot Moens, Janneke Tekstra, Mart A F J van de Laar, Peter M. ten Klooster, Robert Landewé, Piet L. C. M. van Riel, Femke B. G. Lamers-Karnebeek, T.L.Th.A. Jansen, Annemarie M. Schilder, Marieke van Onna, Marc R. Kok
Publikováno v:
BMC Rheumatology, 3
BMC Rheumatology, Vol 3, Iss 1, Pp 1-8 (2019)
BMC Rheumatology, 3(3), 1-8. BioMed Central
BMC Rheumatology, 3(1):22. BioMed Central Ltd.
BMC Rheumatology
BMC Rheumatology, Vol 3, Iss 1, Pp 1-8 (2019)
BMC Rheumatology, 3(3), 1-8. BioMed Central
BMC Rheumatology, 3(1):22. BioMed Central Ltd.
BMC Rheumatology
Background The aim of this study was to identify predictors of prolonged disease control after discontinuation of tumor necrosis factor inhibitor (TNFi) treatment in patients with rheumatoid arthritis (RA). Methods Post-hoc analysis of 439 RA patient
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e33226c54c43180fa91dac04b4192518
http://hdl.handle.net/2066/208543
http://hdl.handle.net/2066/208543
Autor:
Paul Baudoin, Zoltán Szekanecz, R. Bos, H G Raterman, L. Hartman, Cornelia F Allaart, E. N. Griep, Daniela Opris-Belinski, Ruth Klaasen, Annemarie M. Schilder, Frank Buttgereit, Sabrina Paolino, Marc R. Kok, Maarten Boers, W.F. (Willem) Lems, Thomas Klausch, P. Masaryk, J. A. P. Da Silva, M. Cutolo
Publikováno v:
Annals of the Rheumatic Diseases. 80:1107.1-1107
Background:Treatment with low-dose glucocorticoids (GCs) (≤7.5 mg prednisolone) in combination with standard care is highly effective in rheumatoid arthritis (RA), but despite 70 years of clinical experience, evidence-based information on its balan
Autor:
Mart A F J van de Laar, Eddy M. M. Adang, Piet L. C. M. van Riel, Sofie H M Manders, T.L.Th.A. Jansen, Henk Visser, Wietske Kievit, Jan N Stolk, Annemarie M. Schilder, Harald E. Vonkeman
Publikováno v:
The Journal of Rheumatology, 43, 10, pp. 1787-1794
The Journal of Rheumatology, 43, 1787-1794
The Journal of Rheumatology, 43, 1787-1794
Objective.To analyze and compare the effectiveness and drug survival in patients with rheumatoid arthritis, as measured by 28-joint Disease Activity Score (DAS28) and Health Assessment Questionnaire–Disability Index (HAQ-DI), of tumor necrosis fact
Autor:
Willem F. Lems, Henk Visser, Piet L. C. M. van Riel, Marjan Ghiti Moghadam, Dirk Jan Van Schaardenburg, Eric H. Sasso, Harald E. Vonkeman, Annemarie M. Schilder, Mart A F J van de Laar, Peter M. ten Klooster, Femke B. G. Lamers-Karnebeek, Janneke Tekstra, Robert Landewé, T.L.Th.A. Jansen, David Chernoff, Timothy R D J Radstake, Hein J. Bernelot Moens
Publikováno v:
on behalf of the Dutch National POET Collaboration 2018, ' Multi-biomarker disease activity score as a predictor of disease relapse in patients with rheumatoid arthritis stopping TNF inhibitor treatment ', PLoS ONE, vol. 13, no. 5, e0192425 . https://doi.org/10.1371/journal.pone.0192425
PLoS ONE [E], 13(5). Public Library of Science
PLoS ONE, 13(5):e0192425. Public Library of Science
PLoS ONE
PLoS One, 13, 5
PLoS One, 13
PLoS ONE, Vol 13, Iss 5, p e0192425 (2018)
PLoS ONE [E], 13(5). Public Library of Science
PLoS ONE, 13(5):e0192425. Public Library of Science
PLoS ONE
PLoS One, 13, 5
PLoS One, 13
PLoS ONE, Vol 13, Iss 5, p e0192425 (2018)
Objective Successfully stopping or reducing treatment for patients with rheumatoid arthritis (RA) in low disease activity (LDA) may improve cost-effectiveness of care. We evaluated the multi-biomarker disease activity (MBDA) score as a predictor of d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::33894034e91d3de5e5b610dd849b64d8
https://research.vumc.nl/en/publications/45c10ad2-3ce2-498d-83ae-1096281a0bc5
https://research.vumc.nl/en/publications/45c10ad2-3ce2-498d-83ae-1096281a0bc5
Autor:
Mart A F J van de Laar, Tim J Jansen, Sofie H M Manders, Annemarie M. Schilder, Eddy M. M. Adang, Piet L. C. M. van Riel, Harald E. Vonkeman, Wietske Kievit, Henk Visser, Jan N Stolk
Publikováno v:
Annals of the rheumatic diseases, 74(3). BMJ Publishing Group
Annals of the Rheumatic Diseases, 74, e24
Annals of the Rheumatic Diseases, 74, 3, pp. e24
Annals of the Rheumatic Diseases, 74, e24
Annals of the Rheumatic Diseases, 74, 3, pp. e24
Tumour necrosis factor inhibitor (TNFi) treatment in patients with rheumatoid arthritis is more effective when combined with methotrexate (MTX).1–3 However, little is known about which MTX dose to use. With great interest, we read the article by Bu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::62291e7034132a1860670a51dfb689db
https://research.utwente.nl/en/publications/60b516a7-c863-465a-bcec-0ad727bc588e
https://research.utwente.nl/en/publications/60b516a7-c863-465a-bcec-0ad727bc588e
Autor:
Aaltje Y, Adema, Annemarie M, Schilder, Tim C M A, Schreuder, Karin, Grünberg, Irine E M, Bultink, Chris J J, Mulder
Publikováno v:
Journal of gastrointestinal and liver diseases : JGLD. 19(2)
A 67-year-old male presented with ascites, dyspnoea, peripheral edema and purpura. The history revealed asthma and nasal polyps. The laboratory tests showed an increased peripheral blood eosinophilic cell count. The ascitic fluid analysis showed feat